Avadel Pharmaceuticals PLC (STU:AWK)
€ 9.85 0.4 (4.23%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.32 GF Score: 40/100

Q2 2024 Avadel Pharmaceuticals PLC Earnings Call Transcript

Aug 08, 2024 / 12:30PM GMT
Release Date Price: €14.5 (-1.36%)
Operator

Greetings, and welcome to Avadel Pharmaceuticals Second Quarter 2024 Earnings Call. (Operator Instructions) The question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.

It is now my pleasure to introduce Austin Murtagh with Precision AQ. Thank you. You may begin.

Austin Murtagh
Stern Investor Relations - IR

Good morning, and thank you for joining us on our conference call to discuss Avadel's second quarter 2024 results. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements.

These risks and uncertainties are described in Avadel's public filings under the Exchange Act included in the Form 10-K for the year ended December 31, 2023, which was filed on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot